Programmed Cell Death Ligand 1 Is Essential for Electroacupuncture-Mediated Analgesia in the Cerebellum of Fibromyalgia Mice.

Fibromyalgia is a chronic pain condition that primarily affects women and can significantly impact quality of life. Researchers recently investigated how electroacupuncture (acupuncture with mild electrical stimulation) might help relieve fibromyalgia pain in mice, and what biological mechanisms make it work.

The study used mice exposed to intermittent cold stress to create fibromyalgia-like symptoms, including increased sensitivity to touch and temperature. The researchers found that electroacupuncture treatment effectively reduced this pain hypersensitivity. They discovered that electroacupuncture works by increasing levels of a protein called PD-L1 in the cerebellum, a brain region involved in pain processing.

When the scientists artificially increased PD-L1 levels, it produced pain relief similar to electroacupuncture. Conversely, when they blocked PD-L1 from working, electroacupuncture lost its pain-relieving effects. The study also found that electroacupuncture reduced the expression of TRPV1, a pain receptor, and decreased activity of pain-signaling enzymes in the brain.

What does this mean for fibromyalgia patients? This research helps explain the biological basis for why electroacupuncture may reduce pain, supporting its potential as a treatment option. The PD-L1/PD-1 pathway represents a novel mechanism through which acupuncture affects pain processing in the nervous system. While this study was conducted in mice and human trials are needed, it adds to growing evidence that electroacupuncture can provide meaningful pain relief for fibromyalgia through specific, measurable biological changes in the brain.

If you're considering electroacupuncture for fibromyalgia, consult with a licensed acupuncturist experienced in treating chronic pain conditions.

This study investigated electroacupuncture's mechanism of action in fibromyalgia using an intermittent cold stress (ICS) mouse model. Mice (n=9 per group) developed mechanical hyperalgesia (2.02±0.13g on day 4) and thermal hyperalgesia (4.28±0.21s). Electroacupuncture treatment effectively reversed these symptoms through the PD-L1/PD-1 pathway in the cerebellum.

Key methodology included ICV injection of PD-L1, TRPV1 knockout models, and PD-L1-neutralizing antibodies to confirm mechanism specificity. Results showed fibromyalgia mice exhibited decreased cerebellar PD-1 expression with elevated TRPV1 and pain-related kinase activity. Both electroacupuncture and exogenous PD-L1 administration restored PD-1 expression and suppressed TRPV1 signaling. When PD-L1 was neutralized, electroacupuncture's analgesic effects were abolished, confirming PD-L1 as the critical mediator.

Clinical implications: This research identifies the PD-L1/PD-1 pathway as a novel neurobiological target for electroacupuncture in fibromyalgia treatment, suggesting cerebellar modulation of pain processing as a key therapeutic mechanism. These findings support electroacupuncture as an evidence-based intervention for fibromyalgia management.